RIDGEBACK CAPITAL
Ridgeback Capital is a private investment firm that focuses on private and public companies in the life sciences sector. The company was founded in 2006 by Dr. Holman and is headquartered in New York, NY.
RIDGEBACK CAPITAL
Social Links:
Industry:
Biotechnology Finance Financial Services
Founded:
2006-01-01
Status:
Active
Contact:
212-624-2600
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta SPF Google Font API LetsEncrypt Content Delivery Network Domain Not Resolving Euro Organization Schema Person Schema COVID-19
Similar Organizations
Casdin Capital
Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry.
Clarus Ventures
Clarus Ventures is a Massachusetts-based venture capital firm focused on investments in the healthcare sector.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-02 | Crisp | Ridgeback Capital investment in Series B - Crisp | 35 M USD |
| 2021-12-07 | Freenome | Ridgeback Capital investment in Series D - Freenome | 300 M USD |
| 2021-11-29 | Quell Therapeutics | Ridgeback Capital investment in Series B - Quell Therapeutics | 156 M USD |
| 2021-11-09 | Arbor Biotechnologies | Ridgeback Capital investment in Series B - Arbor Biotechnologies | 215 M USD |
| 2021-09-23 | Garuda Therapeutics | Ridgeback Capital investment in Series A - Garuda Therapeutics | 72 M USD |
| 2021-07-14 | Turnstone Biologics | Ridgeback Capital investment in Series D - Turnstone Biologics | 80 M USD |
| 2021-05-06 | TwinStrand Biosciences | Ridgeback Capital investment in Series B - TwinStrand Biosciences | 50 M USD |
| 2021-03-30 | Pyxis Oncology | Ridgeback Capital investment in Series B - Pyxis Oncology | 152 M USD |
| 2021-03-16 | Acepodia | Ridgeback Capital investment in Series B - Acepodia | 47 M USD |
| 2021-03-03 | Caribou Biosciences | Ridgeback Capital investment in Series C - Caribou Biosciences | 115 M USD |